Affordable access to proteins and micronutrients in daily food is still an issue for low and middle income groups. As part of the needed protein transition TNO has chosen insects as an important source for nutritious food and an income generator. Interest in insects is growing in Europe and Africa. TNO is founder of the Flying Food consortium and jointly we create access to affordable proteins and livelihood, by setting up an inclusive value chain on crickets for human consumption, in low and middle income countries.
Good food and jobs
In the last 4 years, the Flying Food consortium established the rearing, processing and retailing of crickets in Kenya and Uganda. With the lessons learned there, the concept Flying Food is reproducible to other regions and countries with a solid business model.
Ambition is to scale Flying Food to 5 other countries in sub-Saharan Africa and create 15.000 jobs, especially for women and youth, reduce malnutrition by providing 200.000 servings annually and reduce the carbon footprint by boosting this climate smart protein source.
Results Flying Food study in Burundi
A recent study proves producing crickets as a human food alternative both technically and economically feasible.
Flying Food Consortium
The Flying Food consortium exists of four partners from the Netherlands: TNO, Wageningen Food & Biobased Research, Protifarm Ltd and New Generation Nutrition Ltd. The Flying Food consortium establishes public private partnerships in sub-Sahara Africa, develops new projects, attracts funding and investment capital, transfers knowledge and experience on the cricket business to local partners and guides the innovation of the new cricket value chain.
More information is provided on the website of the Flying Food Consortium. Also technical guidelines for rearing crickets on small and medium scale and key figures for the business case are provided here.
Watch the video for more information about crickets for food and jobs in Africa.
Crickets in Africa
Discover how the Flying Food Consortium takes the next step in protein transition with crickets in Africa.
Insects for food or feed
We have chosen for insects, specifically crickets, directly for human consumption and not for chicken or fish feed because crickets are healthy, tasty and affordable for humans. Furthermore crickets are an efficient and sustainable food source with attractive business opportunities for farming and processing them into food products. Fish and chicken are much more expensive for our target group.
Market study Flying Food in Rwanda
Results of this market study show a business opportunity for crickets for human consumption in Rwanda. This study was conducted by TNO, ICCO and Nutrifarm.
Mathilde MiedemaFunctie:Programme Director
With TNO Innovation for Development (I4D), Mathilde Miedema launches innovative solutions for societal problems in low and middle-income countries. In this way, TNO helps to create greater equality in the world.
Standplaats:Leiden - Sylviusweg
Telefoon:+31 88 866 53 28
LinkedIn:Mathilde on LinkedIn
Looking for an expert?View all experts
Flying Food takes next step in protein transition with crickets in Africa
With the Flying Food project, TNO, together with partners, is committed to accelerating the protein transition in Africa. The Flying Food consortium is setting up a value chain using crickets as a healthy food.
Ancora Health develops personal diabetes plan with 360 methodology
With the help of TNO's knowledge of diabetic typing, Ancora Health wants to implement a diabetes lifestyle programme within healthcare.
MixMasters uses TNO phenotype test to offer personalised nutrition
TNO is helping MixMasters answer the question 'How can we personalise while remaining user-friendly?' Moreover, during their collaboration, the idea for a new concept was born: FoodiYou.
Personalised Health: Take it personal
TNO helps companies develop scientifically based personalised health applications. Knowledge is translated into applications by using a systems approach, and personalised health is put into practice. An example of this is the collaboration with Gabriele Ronnett of Johnson & Johnson Consumer Health Company.
Ex vivo organ perfusion provides accurate drug development data
TNO uses ex vivo normothermic organ perfusion to more accurately determine ADME processes for specific compounds and accelerate drug development.